Skip to main content
. Author manuscript; available in PMC: 2015 Oct 1.
Published in final edited form as: Appl Biochem Biotechnol. 2014 Apr 11;174(3):1115–1126. doi: 10.1007/s12010-014-0894-2
Substrate Immobilizing
Matrix
Detection
Limit
Sensitivity Sample Technique Ref
Au IDμEs DTSP SAM 0.36 pg mL−1 3.2 kΩ (pg mL−1)−1 Saliva/ ISF EIS [35]
Au IDμEs DTSP SAM 0.36 pg mL−1 7.9 kΩ (pg mL−1)−1 Saliva EIS [37]
PANI protected Au Nanoparticles/ Au IDμEs EDC/NHS 0.36 pg mL−1 4.5 µA (g mL−1)−1 Cortisol in PBS solution CV, DPV [39]
Coreshell Ag@AgO-PANI/ Au IDμEs EDC/NHS 0.64 pgmL−1 183 µA (g mL−1)−1 Cortisol in PBS CV [40]
Reduced Graphene (rGo)/Au IDA - 1 ng mL−1 - Saliva CV [41]
Au IDμEs DTSP SAM 0.36 pg mL−1 6.4 kΩ (pg mL−1)−1 ISF EIS [45]
Screen Printed Carbon Electrode Potein A-modified magnetic particle 3.5 pg mL−1 - Serum DPV [46]
Au Nanoparticle/Au IDμEs DTBP-Protein G Scaffold 16 pg mL−1 1.6 µA (pg mL−1)−1 Blood Square wave voltammetry [47]
Pt Electrode NHS-WSC SAM 1 ng mL−1 200 nA (200mg dL−1)−1 Saliva Current by GOD-cortisol reaction [48]
Au IDμEs DTSP SAM 10 pg mL−1 6 µA (pg mL−1)−1 Saliva CV [49]